OLIVIER JALLABERT

About OLIVIER JALLABERT

Olivier Jallabert is the founder of Amplitude Surgical, a French company specialized in surgical technologies for lower-limb orthopedics, established in 1997 in Valence. He serves as Chief Executive Officer and has been central to building the group into one of France’s leading players in its field. Before founding Amplitude Surgical, he gained substantial experience within major U.S. healthcare groups, notably Biomet, where he held Europe-based R&D responsibilities. That background gave him a strong combination of industrial, technical, and international expertise that has shaped his leadership style. At Amplitude Surgical, Jallabert has led the company’s growth strategy around product innovation, manufacturing quality, and international commercial expansion. Under his leadership, the group developed a broad portfolio of implants and surgical instruments for hip, knee, and extremity procedures, while strengthening its footprint in France and building a broader international presence. The company has relied on sustained R&D investment, a disciplined quality system, and a commercial model designed to support gradual entry into new markets, including Australia, Brazil, and the United States. His governance approach reflects a long-term entrepreneurial mindset, balancing strategic vision with close operational involvement. Company documents state that he founded the group in 1997 and that he has more than 25 years of experience in the orthopedics industry. His career demonstrates a rare level of expertise in the design, development, and commercialization of premium medical devices. He also guided Amplitude Surgical through its public listing and the company’s evolution into an international medtech platform. Jallabert stands out as an industrial entrepreneur with a clear ability to scale a French medtech business in a highly competitive market while preserving a differentiated technological position and a durable international ambition. His profile combines founder-led leadership, sector specialization, and a strong track record in orthopedic innovation and business development.